GoodRx Holdings (GDRX) Operating Leases (2019 - 2026)

GoodRx Holdings has disclosed Operating Leases across 8 years of filings, most recently posting $49.0 million for Q1 2026.

• Operating Leases for Q1 2026 came in at $49.0 million, up 9.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $49.0 million (up 9.28% YoY), and the FY2025 annual result was $49.8 million, up 8.14% from the prior year.
• Operating Leases came in at $49.0 million for Q1 2026 at GoodRx Holdings, down from $49.8 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $56.3 million in Q1 2023 to a low of $32.5 million in Q1 2022.
• The 5-year median for Operating Leases is $49.3 million (2024), against an average of $47.4 million.
• Across the five-year window, Operating Leases surged 73.1% in 2023 and slipped 12.75% in 2025, its largest moves.
• GoodRx Holdings' Operating Leases stood at $54.1 million in 2022, then slipped by 10.58% to $48.4 million in 2023, then slipped by 4.88% to $46.0 million in 2024, then gained by 8.14% to $49.8 million in 2025, then dropped by 1.68% to $49.0 million in 2026.
• The last three Operating Leases figures came in at $49.0 million (Q1 2026), $49.8 million (Q4 2025), and $51.3 million (Q3 2025), per Business Quant data.